Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Jul 13;5(6):794–803. doi: 10.1002/ags3.12489

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 The Authors. Annals of Gastroenterological Surgery published by John Wiley & Sons Australia, Ltd on behalf of The Japanese Society of Gastroenterology

This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.

PMC Copyright notice

Kaplan‐Meier overall survival according to pre‐treatment prognostic score. (A) Pre‐treatment prognostic score 0 (n = 12) 4.7 months, pre‐treatment prognostic score 1 (n = 51) MST 2.87 months, pre‐treatment prognostic score 2 (n = 70) MST 5.53 months, pre‐treatment prognostic score 3 (n = 71) MST 10.1 months, pre‐treatment prognostic score 4 (n = 56) MST 17.6 months, pre‐treatment prognostic score 5 (n = 18) MST 22.4 months. (B) Pre‐treatment low prognostic score (0‐1) (n = 63) MST 2.97 months, pre‐treatment medium prognostic score (2‐3) (n = 141) MST 6.63 months, pre‐treatment high prognostic score (4‐5) (n = 74) MST 18.3 months. Pre‐treatment high prognostic score group showed significantly better OS compared with pre‐treatment medium prognostic score group (P < .001). Pre‐treatment medium prognostic score group showed significantly better OS compared with low pre‐treatment prognostic score group (P < .001). MST, median survival time; OS, overall survival